Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer ® -Accredited Facilities in the United States.
Collin A SitlerChunqiao TianChad A HamiltonMichael T RichardsonJohn K ChanDaniel S KappCharles A LeathYovanni CasablancaChristina WashingtonNicole P ChappellAnn H KloppCraig D ShriverChristopher M TarneyNicholas W BatemanThomas P ConradsGeorge Larry MaxwellNeil T PhippenKathleen M DarcyPublished in: Cancers (2024)
IMT was associated with a consistent survival benefit in real-world patients with stage IVB cervical cancer.